Inhibition of the gastrointestinal absorption of p‐ aminosalicylate (PAS) in rats and humans by diphenhydramine
J. Lavigne,Claudel Marchand
DOI: https://doi.org/10.1002/cpt1973143404
1973-05-01
Clinical pharmacology and therapy
Abstract:Injection of diphenhydramine, 25 mg per kilogram, intraperitoneally, decreased the blood concentration of sodium p‐aminosalicylate (PAS), 200 mg per kilogram, administered per os. This effect was observed 10,20,30,45, and 60 minutes after administration of PAS. A dose‐response study (2 to 25 mg per kilogram) revealed that the effect was proportional to the dose of diphenhydramine. The decrease in blood concentration of PAS was associated with a similar decrease in the PAS levels in brain, lung, liver, lipids, muscle, and kidney of animals treated with diphenhydramine. PAS levels in the stomach after diphenhydramine, revealed that more than 20% of the PAS remained in the stomach 45 minutes after oral administration but only 3% remained in the stomach in the control animals. Study of the gastrointestinal peristalsis with 51Cr indicated that, 45 minutes after injection of diphenhydramine, 60% of the radioactive marker was found in the stomach, whereas less than 10% was recovered in the stomach of control rats in which most of 51Cr was located in the first segment of the ileum. Human volunteers treated with diphenhydramine, 50 mg intramuscularly, 10 minutes before ingestion of PAS, 2 gm, had significantly less PAS in the blood 10 minutes after ingestion. These observations indicate the importance of the gastrointestinal tract as a site of drug interaction.